Unaudited Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Series A Preferred Stock	Preferred Stock Series A Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance, preferred stock, outstanding (in shares) at Dec. 31, 2023			0
Beginning balance at Dec. 31, 2023	$ 337,663		$ 0	$ 45	$ 652,880	$ (345)	$ (314,917)
Beginning balance, common stock, outstanding (in shares) at Dec. 31, 2023				45,167,225
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	6,183				6,183
Stock issued - on vested RSAs (in shares)				522,358
Stock issued – on vested RSAs	1			$ 1
Foreign currency translation	(203)					(203)
Unrealized loss on available-for-sale securities	(18)					(18)
Net loss	(10,221)						(10,221)
Ending balance, preferred stock, outstanding (in shares) at Mar. 31, 2024			0
Ending balance at Mar. 31, 2024	333,405		$ 0	$ 46	659,063	(566)	(325,138)
Ending balance, common stock, outstanding (in shares) at Mar. 31, 2024				45,689,583
Beginning balance, preferred stock, outstanding (in shares) at Dec. 31, 2024		0	0
Beginning balance at Dec. 31, 2024	$ 348,909		$ 0	$ 47	683,939	24	(335,101)
Beginning balance, common stock, outstanding (in shares) at Dec. 31, 2024	46,906,765			46,906,765
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	$ 4,153				4,153
Stock option exercises (in shares)	0
Stock issued – on vested RSUs (in shares)				641,666
Stock issued – on vested RSUs	$ 1			$ 1
Unrealized loss on available-for-sale securities	9					9
Net loss	(448)						(448)
Ending balance, preferred stock, outstanding (in shares) at Mar. 31, 2025		0	0
Ending balance at Mar. 31, 2025	$ 352,624		$ 0	$ 48	$ 688,092	$ 33	$ (335,549)
Ending balance, common stock, outstanding (in shares) at Mar. 31, 2025	47,548,431			47,548,431